Jan Blankensteijn

PROF.DR.

20092019
If you made any changes in Pure these will be visible here soon.

Activities 2017 2017

  • 8 Oral presentation

In vitro experiments and implications for Ch-EVAS

JP Meekel (Speaker), TG van Schaik (Speaker), RJ Lelij (Speaker), W Wisselink (Speaker), KK Yeung (Speaker), JD Blankensteijn (Speaker)
23 Mar 201724 Mar 2017

Activity: Talk or presentationOral presentation

Reorganisatie van de aortawand door periaortaal vetweefsel in atherosclerotische en aneurysmatische aorta.

JP Meekel (Speaker), TG van Schaik (Speaker), JJM Hoozemans (Speaker), RJ Lelij (Speaker), W Wisselink (Speaker), JD Blankensteijn (Speaker), KK Yeung (Speaker)
11 May 201712 May 2017

Activity: Talk or presentationOral presentation

In-vitro studies naar verbetering in de aansluiting van parallelle stentgrafts bij endovasculair herstel met Nellix in juxtarenale aorta aneurysmata

TG van Schaik (Speaker), JP Meekel (Speaker), RJ Lelij (Speaker), M Truijers (Speaker), AWJ Hoksbergen (Speaker), W Wisselink (Speaker), JD Blankensteijn (Speaker), KK Yeung (Speaker)
11 May 2017

Activity: Talk or presentationOral presentation

In Vitro Studies Show How To Improve The Results Of Ch/EVAR And Ch/EVAS With The Nellix Graft

JD Blankensteijn (Speaker)
14 Nov 2017

Activity: Talk or presentationOral presentation

Characterization of abdominal adipose tissue deposits in aortic pathology.

JP Meekel (Speaker), N Bogunovic (Speaker), JJM Hoozemans (Speaker), TG van Schaik (Speaker), RJ Lelij (Speaker), W Wisselink (Speaker), JD Blankensteijn (Speaker), KK Yeung (Speaker)
10 Nov 2017

Activity: Talk or presentationOral presentation

Accelerating thrombolysis of peripheral arterial occlusions with therapeutic microbubbles and ultrasound.

HP Ebben (Speaker), JH Nederhoed (Speaker), RJ Lelij (Speaker), AWJ Hoksbergen (Speaker), O Kamp (Speaker), RJP Musters (Speaker), JD Blankensteijn (Speaker), W Wisselink (Speaker), KK Yeung (Speaker)
May 2017

Activity: Talk or presentationOral presentation